0.0235USD
273.00 KUSD
10.14 MUSD
About Rafarma Pharmaceuticals, Inc. (WY)
Rafarma Pharmaceuticals, Inc. engages in the manufacture and marketing of pharmaceutical goods. It produces all types of medical drugs in all delivery methods for various pharmacological groups. The company was founded on May 26, 2004 and is headquartered in Draper, UT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RAFA is 0.1020 USD — it has decreased by 5.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Rafarma Pharmaceuticals, Inc. (WY) stocks are traded under the ticker RAFA.
RAFA stock is 5.88% volatile and has beta coefficient of 1.84. Check out the list of the most volatile stocks — is Rafarma Pharmaceuticals, Inc. (WY) there?
Yes, you can track Rafarma Pharmaceuticals, Inc. (WY) financials in yearly and quarterly reports right on TradingView.
RAFA stock has fallen by 17.01% compared to the previous week, the month change is a 32.45% fall, over the last year Rafarma Pharmaceuticals, Inc. (WY) has showed a 66.12% decrease.
RAFA net income for the last quarter is −856.00 K USD, while the quarter before that showed 1.77 M USD of net income which accounts for −148.25% change. Track more Rafarma Pharmaceuticals, Inc. (WY) financial stats to get the full picture.
Today Rafarma Pharmaceuticals, Inc. (WY) has the market capitalization of 10.06 M, it has decreased by 17.63% over the last week.
No, RAFA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RAFA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rafarma Pharmaceuticals, Inc. (WY) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rafarma Pharmaceuticals, Inc. (WY) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rafarma Pharmaceuticals, Inc. (WY) stock shows the sell signal. See more of Rafarma Pharmaceuticals, Inc. (WY) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Rafarma Pharmaceuticals, Inc. (WY) EBITDA is 4.48 M USD, and current EBITDA margin is 3.09%. See more stats in Rafarma Pharmaceuticals, Inc. (WY) financial statements.